Aligos Therapeutics Inc. (ALGS)
NASDAQ: ALGS
· Real-Time Price · USD
10.51
0.13 (1.25%)
At close: Oct 16, 2025, 3:59 PM
10.40
-1.05%
After-hours: Oct 16, 2025, 04:54 PM EDT
1.25% (1D)
| Bid | 9.64 |
| Market Cap | 64.65M |
| Revenue (ttm) | 3.17M |
| Net Income (ttm) | -74.18M |
| EPS (ttm) | -13.27 |
| PE Ratio (ttm) | -0.79 |
| Forward PE | -1.42 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 11.2 |
| Volume | 248,156 |
| Avg. Volume (20D) | 76,646 |
| Open | 10.38 |
| Previous Close | 10.38 |
| Day's Range | 10.18 - 11.20 |
| 52-Week Range | 3.76 - 46.80 |
| Beta | 2.77 |
| Ex-Dividend Date | n/a |
About ALGS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALGS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALGS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAligos Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+13.9%
Aligos Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
7 months ago
-19.55%
Aligos Therapeutics shares are trading lower after the company reported Q4 financial results and missed its EPS estimate.
